Corvus Pharmaceuticals Inc (CRVS)

Stockholders Equity

$225.33M

Quarterly · Period ending: · USD

CRVS logo

CRVS Stockholders Equity

Latest reported$225.33M
CRVS Quarterly Shareholders Equity ($9.85M → $225.33M)
High-resolution chart · PNG

CRVS stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Corvus Pharmaceuticals Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
225,328,000
240,679,000
61,205,000
71,768,000
80,228,000
49,325,000
32,568,000
12,409,000
51,226,000
33,364,000
38,684,000
44,289,000
49,483,000
48,867,000
56,115,000
64,681,000
80,386,000
89,722,000
97,162,000
105,148,000
96,403,000
94,385,000
72,148,000
42,350,000
50,840,000
60,035,000
71,111,000
80,413,000
89,654,000
100,697,000
110,336,000
118,847,000
127,399,000
137,228,000
84,835,000
93,737,000
104,782,000
118,225,000
132,801,000
142,910,000
151,968,000
152,550,000
-31,101,000
-25,310,000
9,852,000
9,852,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.